Combination Of Cord Blood T Regulatory Cells With Ruxolitinib Decreases Side Effects And Improves Survival In Xenogenic Graft Vs. Host DiseaseKe Zeng,Meixian Huang,Li Li,Mi-Ae Lyu,Hongbing Ma,Mitsutaka Nishimoto,Tara Sadeghi,Sairah Ahmed,Borje S. Andersson,Simrit ParmarBLOOD(2020)引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要